Course description
The aim of this course is to give students a basic understanding of health economic considerations of ATMPs (advanced therapy medicinal products).
The focus is on methods for economic evaluation and health technology assessment (HTA) and patient access requirements in Sweden. With the acquired knowledge and skills, the students will be able to describe and discuss reimbursement processes and patient access considerations for ATMPs, and to contribute to the planning and implementation of economic evaluations and HTAs for ATMPs.
The course includes lectures, guest lectures, a guest lecturer panel discussion, group and individual work, and seminars, both campus- and distance-based.
Requirements and Selection
Entry requirements
Registered PhD-student or PhD-degree in relevant subject. PhD-students from National Research School of ATMP are given priority to admission. We welcome participants from all Swedish and international universities that are involved in research activities related to ATMP.
Selection
Selection is performed according to the following:
- PhD students at Sahlgrenska Academy,
- PhD students enrolled at another university within a formal collaborative agreement on doctoral education with Sahlgrenska Academy,
- PhD students enrolled at another faculty at the University of Gothenburg or another university in Sweden,
- PhD students enrolled at a university outside Sweden.
Other information
Course coordinator: Pia Johansson, pia.johansson@gu.se
Course administrator: Marie Göthlund, marie.gothlund@gu.se
Course dates: 16 - 20 November 2026
Number of course spots: 20
Course syllabus
SM00137
Department
Institute of Medicine
Subject
Health Sciences
Type of course
Subject area course
Research School/Graduate School
National ATMP (Advanced Therapy Medicinal Products) Research School
Keywords
ATMP, Advanced Therapy Medicinal Products, hälsoekonomiska utvärderingar, health technology assessment, economic evaluation, läkemedel för avancerad terapi